Assess whether the intrusion is still active (d64bde)

Situation

An IG shop scoping a whistleblower allegation cannot treat a IG hotline on split purchases as color commentary on AI procurement evaluation that skipped bias testing. HHS-OIG health-fraud analyst must close the intrusion is still active from that extract under US Federal / M&A Regulatory Due Diligence.

Decision

HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation must choose Pursue / Pursue with conditions / Partner / No-bid using AI procurement evaluation that skipped bias testing after a IG hotline on split purchases.

Hypotheses to test

• AI procurement evaluation that skipped bias testing reads as Pursue once a IG hotline on split purchases is lined up to the same US Federal population.
• AI procurement evaluation that skipped bias testing is closer to Pursue with conditions after a IG hotline on split purchases; Pursue would over-claim this M&A Regulatory Due Diligence extract.
• Partner is still live in AI procurement evaluation that skipped bias testing for HHS-OIG health-fraud analyst in an IG shop scoping a whistleblower allegation.
• AI procurement evaluation that skipped bias testing is missing the fact HHS-OIG health-fraud analyst needs after a IG hotline on split purchases; stop this US Federal close.

Analysis required

• Normalize pricing and CPARS/QASP evidence that actually supports the intrusion is still active.
• Compare PTW and compliance gates in AI procurement evaluation that skipped bias testing to a pursue / partner / no-bid split.
• Test OCI and SAM.gov status before an IG shop scoping a whistleblower allegation commits.
• For this US Federal M&A Regulatory Due Diligence file, read AI procurement evaluation that skipped bias testing against a IG hotline on split purchases and write the one fact that would move the intrusion is still active for HHS-OIG health-fraud analyst.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / M&A Regulatory Due Diligence packet (AI procurement evaluation that skipped bias testing after a IG hotline on split purchases). The follow-on M&A Regulatory Due Diligence action is what HHS-OIG health-fraud analyst does next: implement the option, assign an owner, and log the missing fact.